南美和中美药代动力学服务市场预测至 2031 年 - 区域分析 - 按药物类型(小分子、大分子和疫苗)、服务类型(临床前 ADME 和人体研究、PK/PD 分析和报告、剂量模拟、风险分析等)、治疗应用(肿瘤学、传染病、神经系统疾病、自身免疫性疾病、妇科疾病、心血管疾病、呼吸系统疾病等)和最终用户(制药和生物技术公司、合同研究组织等)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)


No. of Pages: 86    |    Report Code: BMIRE00030946    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Pharmacokinetics Services Market
2023 年,南美和中美药代动力学服务市场价值为 4003 万美元,预计到 2031 年将达到 6881 万美元;预计 2023 年至 2031 年的复合年增长率为 7.0%。

将药代动力学服务外包给 CRO 推动南美和中美药代动力学服务市场发展

将药代动力学服务外包给合同研究组织 (CRO) 为药品制造商和赞助商提供了多种优势。通过选择这些服务,他们可以经济高效地运营。此外,他们可以专注于灵活工作并为其核心业务带来可扩展性,同时实现快速的周转时间。外包有助于制药公司专注于产品商业化,同时实施能力建设、降低成本和数据管理措施。药物发现过程很复杂,任何错误或错误结果都可能导致重大成本并延迟该过程。 CRO 雇用经验丰富的科学家和研究人员,他们在药代动力学和其他领域拥有专业知识。因此,他们为制药公司提供了获取专业知识的机会,从而无需投资雇用此类熟练劳动力或提供额外培训来培养他们。因此,拥有有前途的候选药物但资源有限的小公司和涉及业务多元化的大公司都选择由组织良好的 CRO 提供的临床研究服务,这促进了药代动力学服务市场的发展。

南美和中美洲药代动力学服务市场概览

巴西是临床试验的主要目的地。根据 Clinical Trials Arena 的数据,2021 年,巴西占全球临床试验活动的 1.7%。2022 年 7 月,波士顿 CRO 收购了位于里约热内卢的巴西临床研究研究所 (IBPClin),这是其在拉丁美洲实施分散式临床试验交付模式的第一步。该公司声称已开展了 160 多项行业赞助的研究,招募了巴西 12 个州的 7,000 多名参与者。IBPClin 是南美洲最大的研究中心。2020 年 3 月,Fiocruz 基金会建立了一个新的医院中心,承诺投资于世界卫生组织 (WHO) 支持的临床试验。这家新医院将承办由 Fiocruz 在巴西领导的团结临床试验,该计划在巴西卫生部科技部的支持下,在巴西 12 个州的 18 家医院实施,并由 INI/Fiocruz 协调。因此,这些为发展临床研究而采取的举措促进了巴西药代动力学服务市场的增长。

南美和中美药代动力学服务市场收入及预测至 2031 年(百万美元)

南美和中美药代动力学服务市场细分

南美和中美药代动力学服务市场分为药物类型、服务类型、治疗应用、最终用户和国家。

根据药物类型,南美和中美药代动力学服务市场分为小分子、大分子和疫苗。小分子部分在 2023 年占据了最大的市场份额。

就服务类型而言,南美和中美药代动力学服务市场分为临床前 ADME 和人体研究、PK/PD 分析和报告、剂量模拟、风险分析等。 2023 年,临床前 ADME 和人体研究部门占据了最大的市场份额。

按治疗应用划分,南美和中美药代动力学服务市场细分为肿瘤学、传染病、神经系统疾病、自身免疫性疾病、妇科疾病、心血管疾病、呼吸系统疾病等。肿瘤学部门在 2023 年占据了最大的市场份额。

按最终用户划分,南美和中美药代动力学服务市场细分为制药和生物技术公司、合同研究组织等。合同研究组织部门在 2023 年占据了最大的市场份额。

按国家划分,南美和中美药代动力学服务市场细分为巴西、阿根廷和南美和中美洲其他地区。2023 年,巴西占据了南美和中美洲药代动力学服务市场份额的主导地位。

Charles River Laboratories International Inc;Eurofins Scientific SE;Certara Inc.; Parexel International Corp;Thermo Fisher Scientific Inc.;Allucent;PACIFIC BIOLABS;和 SGS SA 是南美和中美药代动力学服务市场的一些领先公司。

South & Central America Pharmacokinetics Services Strategic Insights

Strategic insights for South & Central America Pharmacokinetics Services involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-pharmacokinetics-services-market-strategic-framework.webp
Get more information on this report

South & Central America Pharmacokinetics Services Report Scope

Report Attribute Details
Market size in 2023 US$ 40.03 Million
Market Size by 2031 US$ 68.81 Million
Global CAGR (2023 - 2031) 7.0%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 药物类型
  • 小分子
  • 大分子
  • 疫苗
By 服务类型
  • 临床前 ADME 和人体研究
  • PK/PD 分析和报告
  • 剂量模拟
  • 风险分析
By 最终用户
  • 制药和生物技术公司
  • 合同研究组织
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Certara Inc.
  • Parexel International Corp
  • Thermo Fisher Scientific Inc.
  • Allucent
  • PACIFIC BIOLABS
  • SGS SA
  • Get more information on this report

    South & Central America Pharmacokinetics Services Regional Insights

    The regional scope of South & Central America Pharmacokinetics Services refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-pharmacokinetics-services-market-geography.webp
    Get more information on this report

    The List of Companies - South & Central America Pharmacokinetics Services Market

    1. Charles River Laboratories International Inc
    2. Eurofins Scientific SE
    3. Certara Inc.
    4. Parexel International Corp
    5. Thermo Fisher Scientific Inc.
    6. Allucent
    7. PACIFIC BIOLABS
    8. SGS SA
    Frequently Asked Questions
    How big is the South & Central America Pharmacokinetics Services Market?

    The South & Central America Pharmacokinetics Services Market is valued at US$ 40.03 Million in 2023, it is projected to reach US$ 68.81 Million by 2031.

    What is the CAGR for South & Central America Pharmacokinetics Services Market by (2023 - 2031)?

    As per our report South & Central America Pharmacokinetics Services Market, the market size is valued at US$ 40.03 Million in 2023, projecting it to reach US$ 68.81 Million by 2031. This translates to a CAGR of approximately 7.0% during the forecast period.

    What segments are covered in this report?

    The South & Central America Pharmacokinetics Services Market report typically cover these key segments-

  • 药物类型 (小分子, 大分子, 疫苗)
  • 服务类型 (临床前 ADME 和人体研究, PK/PD 分析和报告, 剂量模拟, 风险分析)
  • 最终用户 (制药和生物技术公司, 合同研究组织)
  • What is the historic period, base year, and forecast period taken for South & Central America Pharmacokinetics Services Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Pharmacokinetics Services Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
  • Who are the major players in South & Central America Pharmacokinetics Services Market?

    The South & Central America Pharmacokinetics Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Certara Inc.
  • Parexel International Corp
  • Thermo Fisher Scientific Inc.
  • Allucent
  • PACIFIC BIOLABS
  • SGS SA
  • Who should buy this report?

    The South & Central America Pharmacokinetics Services Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Pharmacokinetics Services Market value chain can benefit from the information contained in a comprehensive market report.